153 related articles for article (PubMed ID: 11834945)
1. Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule.
Lozano JM; González R; Kindelán JM; Rouas-Freiss N; Caballos R; Dausset J; Carosella ED; Peña J
AIDS; 2002 Feb; 16(3):347-51. PubMed ID: 11834945
[TBL] [Abstract][Full Text] [Related]
2. HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals.
Cabello A; Rivero A; Garcia MJ; Lozano JM; Torre-Cisneros J; González R; Dueñas G; Galiani MD; Camacho A; Santamaria M; Solana R; Montero C; Kindelán JM; Peña J
Hum Immunol; 2003 Nov; 64(11):1045-9. PubMed ID: 14602234
[TBL] [Abstract][Full Text] [Related]
3. Induction of cell surface human leukocyte antigen-G expression in pandemic H1N1 2009 and seasonal H1N1 influenza virus-infected patients.
Chen HX; Chen BG; Shi WW; Zhen R; Xu DP; Lin A; Yan WH
Hum Immunol; 2011 Feb; 72(2):159-65. PubMed ID: 21087648
[TBL] [Abstract][Full Text] [Related]
4. Cell surface antigens and function of monocytes and a monocyte-like cell line before and after infection with HIV.
Mann DL; Gartner S; LeSane F; Blattner WA; Popovic M
Clin Immunol Immunopathol; 1990 Feb; 54(2):174-83. PubMed ID: 1967231
[TBL] [Abstract][Full Text] [Related]
5. Modulation of HLA-G antigens expression in myelomonocytic cells.
Onno M; Le Friec G; Pangault C; Amiot L; Guilloux V; Drénou B; Caulet-Maugendre S; André P; Fauchet R
Hum Immunol; 2000 Nov; 61(11):1086-94. PubMed ID: 11137211
[TBL] [Abstract][Full Text] [Related]
6. Soluble HLA-G molecules are increased in lymphoproliferative disorders.
Sebti Y; Le Friec G; Pangault C; Gros F; Drénou B; Guilloux V; Bernard M; Lamy T; Fauchet R; Amiot L
Hum Immunol; 2003 Nov; 64(11):1093-101. PubMed ID: 14602240
[TBL] [Abstract][Full Text] [Related]
7. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
8. Incidence of HIV infection in monocyte subpopulations characterized by CD4 and HLA-DR surface density.
Schnizlein-Bick CT; Sherman MR; Boggs DL; Leemhuis TB; Fife KH
AIDS; 1992 Feb; 6(2):151-6. PubMed ID: 1558713
[TBL] [Abstract][Full Text] [Related]
9. CD8(+)HLA-G(+) regulatory T cells are expanded in HIV-1-infected patients.
Lozano JM; González R; Luque J; Frias M; Rivero A; Peña J
Viral Immunol; 2009 Dec; 22(6):463-5. PubMed ID: 19951184
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of HLA class I antigen expression in CD4+ T lymphocytes from HIV type 1-infected individuals.
Puppo F; Brenci S; Bosco O; Lanza L; Barocci S; Nocera A; Ghio M; Contini P; Setti M; Scudeletti M; Indiveri F
AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1509-16. PubMed ID: 9390750
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel allo-independent HIV-1 virus preparation for use in immunoassays.
Koesters S; Rutherford W; Fowke KR
J Immunol Methods; 2002 Jun; 264(1-2):69-76. PubMed ID: 12191511
[TBL] [Abstract][Full Text] [Related]
12. Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection.
Yan WH; Lin A; Chen BG; Chen SY
J Infect Dis; 2009 Sep; 200(5):820-6. PubMed ID: 19619059
[TBL] [Abstract][Full Text] [Related]
13. Blood soluble human leukocyte antigen G levels are associated with human immunodeficiency virus type 1 infection in Beninese commercial sex workers.
Lajoie J; Massinga Loembe M; Poudrier J; Guédou F; Pépin J; Labbé AC; Alary M; Roger M
Hum Immunol; 2010 Feb; 71(2):182-5. PubMed ID: 19913587
[TBL] [Abstract][Full Text] [Related]
14. Detection of HLA-G5 secreting cells.
Rebmann V; Busemann A; Lindemann M; Grosse-Wilde H
Hum Immunol; 2003 Nov; 64(11):1017-24. PubMed ID: 14602230
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis.
Donaghy L; Gros F; Amiot L; Mary C; Maillard A; Guiguen C; Gangneux JP
Clin Exp Immunol; 2007 Feb; 147(2):236-40. PubMed ID: 17223963
[TBL] [Abstract][Full Text] [Related]
16. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
[TBL] [Abstract][Full Text] [Related]
17. Nucleoside reverse transcriptase inhibitors are able and protease inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients.
Rivero A; Lozano JM; González R; García-Jurado G; Camacho A; Torres-Cisneros J; Peña J
Hum Immunol; 2007 Apr; 68(4):303-6. PubMed ID: 17400067
[TBL] [Abstract][Full Text] [Related]
18. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia.
Nückel H; Rebmann V; Dürig J; Dührsen U; Grosse-Wilde H
Blood; 2005 Feb; 105(4):1694-8. PubMed ID: 15466928
[TBL] [Abstract][Full Text] [Related]
19. Impaired class II expression and antigen uptake in monocytic cells after HIV-1 infection.
Polyak S; Chen H; Hirsch D; George I; Hershberg R; Sperber K
J Immunol; 1997 Sep; 159(5):2177-88. PubMed ID: 9278305
[TBL] [Abstract][Full Text] [Related]
20. Different functional outcomes of intercellular membrane transfers to monocytes and T cells.
HoWangYin KY; Alegre E; Daouya M; Favier B; Carosella ED; LeMaoult J
Cell Mol Life Sci; 2010 Apr; 67(7):1133-45. PubMed ID: 20238479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
